Patentability

Patentability assessment runs alongside the scientific optimization process throughout lead optimization, since a candidate compound's commercial viability...

Patentability assessment runs alongside the scientific optimization process throughout lead optimization, since a candidate compound's commercial viability depends not only on its pharmacological and pharmacokinetic properties but on the strength and breadth of the intellectual property protection that can be secured around it. A patentable pharmaceutical invention must demonstrate novelty (the specific compound or a genus encompassing it must not have been previously disclosed), inventive step (the compound's properties must not be obvious to a person skilled in the art based on existing prior art), and industrial applicability; the comprehensive SAR dataset generated during lead optimization directly supports the breadth of patent claims by demonstrating that the observed biological activity extends across a defined chemical genus rather than being an idiosyncratic property of a single isolated compound, a consideration that increasingly shapes which specific analogues within a SAR series are prioritised for synthesis.